Every Form 4 that Callan JMB Inc. (CJMB) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CJMB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CJMB filings page.
CALLAN JMB INC. director Gerald Dial reported two equity transactions. He made an open-market purchase of 10,000 shares of Common Stock at $0.762 per share, bringing his direct holdings to 12,000 shares. He also received a grant of options covering 25,000 shares of Common Stock that were granted on the first day of the company’s Initial Public Offering. According to the grant terms, the option vests on February 4, 2026 and expires on February 4, 2035, aligning the award with longer‑term company performance.
CALLAN JMB INC. Chief Medical Officer David J. Croyle reported an open-market purchase of 10,195 shares of common stock at $1.75 per share on behalf of a rollover IRA. After this transaction, his indirect holdings reported in the filing total 800,000 shares, indicating a modest increase in his existing position.
CALLAN JMB INC. Chief Medical Officer and 10% owner David J. Croyle reported an indirect open-market purchase of 14,805 shares of Common Stock at $1.762 per share through a Rollover IRA on March 6, 2026. Following this transaction, his indirect holdings total 789,805 shares, making this a relatively small addition to an already substantial position.
Callan JMB Inc. director Gerald Dial reported buying common stock and receiving stock options. On December 30, 2025, he purchased 461 shares of Callan JMB common stock at $1.22 per share and 1,539 shares at $1.20 per share, bringing his directly held common stock to 2,000 shares.
Separately, on February 4, 2025, he was granted an option to buy 25,000 shares of common stock at an exercise price of $4.00 per share, expiring on February 4, 2035. According to the disclosure, this option was granted on the first day of the company’s initial public offering and will vest on the first anniversary of the IPO closing, on February 4, 2026.
Callan JMB Inc. insider Wayne D. Williams reported buying additional shares of the company’s common stock. On 12/16/2025, Williams acquired 5,000 shares of Callan JMB Inc. common stock in an open market purchase coded as “P” at a price of $1.73 per share, held indirectly through Health Hero America, LLC.
After this transaction, Williams beneficially owned 84,355 shares of common stock through Health Hero America, LLC and also held other direct and indirect positions, including 2,267,488 shares held directly and 25,625 shares held indirectly through Warehouse Asset Management, LLC. Williams serves as CEO, Chairman, President, director and a 10% owner of Callan JMB Inc.
Callan JMB Inc. CEO, chairman and president Wayne D. Williams, who is also a director and 10% owner, reported open-market purchases of the company’s common stock. On December 11, 2025 he bought 62 shares at $1.79 per share, and on December 12, 2025 he bought 4,926 shares at $1.75 per share, bringing his direct beneficial ownership to 2,267,488 shares. On December 15, 2025 he purchased 10,810 shares at $1.70 per share through Health Hero America, LLC, which then held 79,355 shares for him indirectly, alongside 25,625 shares held indirectly through Warehouse Asset Management, LLC.
Callan JMB Inc. CEO, Chairman and President Wayne D. Williams, who is also a director and 10% owner, reported insider purchases of the company’s common stock on 12/10/2025 and 12/11/2025. The transactions used code “P” for purchases.
Through Health Hero America, LLC, which he solely owns, he acquired 13,689 and 30,856 shares at $1.65 per share, bringing that entity’s beneficial holdings to 68,545 shares after the later trade. He also reports beneficial ownership of 2,262,500 shares directly and 25,625 shares indirectly through Warehouse Asset Management, LLC, in which he holds a 41% ownership interest.